Azin Alizadehasl

Azin Alizadehasl (Persian: آذین علیزاده اصل, born 1975) is an Iranian Professor of Cardiology, Echocardiologist and CardioOncologist. She is currently the pioneer and head of Cardio-Oncology department and research center and faculty member of Rajaie Heart Center in Tehran, Iran.She is also fellowship of American Society of Echocardiography, Member at Large positions on ASE Guidelines and Standards Committee till 2020 and fellowship of American College of Cardiology.

Early life
Azin Alizadehasl born on 1975 in Urmia, Iran. She is an Iranian Professor of Cardiology, Echocardiologist and CardioOncologist. She is currently the pioneer and head of Cardio-Oncology department and research center in Rajaie Heart Center in Tehran, Iran. She is also fellowship of American Society of Echocardiography. She studied in General medicine in Tabriz University of Medical Sciences from 1993 to 2000, She also holds Board certified in cardiology from Iran and Tabriz University of Medical Sciences. Alizadehasl ranked second (silver medal) in the World Olympiad of Chemistry in Italy (February 1992); ranked second in Cardiovascular Residency Program Exam in IRAN at 2002; and ranked as first 10% of Iranian Cardiology Board Exam in 2006. She got International Doody’s Core Titles Award for Practical Cardiology Book and Book-authority selected author for 100 Best Cardiology Books of All Time

Career
Alizadeasl was the founder of the first cardio-oncology clinic and department in Iran at Shaheed Rajaie Cardiovascular Medical and Research Center, that was the first cardio-oncology clinic, educational, and research center, in the Middle East. She is also the author and editor of numerous national and international books with valuable publishing companies such as Elsevier, Springer, Cambridge and Jaypee. She has an innovation in Echocardiography field with name of HOLTER ECHOCARDIOGRAPHY and also accepted innovation with name of A Polypill for prevention of cardiotoxicity including Carvedilol, Lisinopril, Aldactone and Atorvastatin by research deputy of Iranian ministry of health and also accepted innovation with name of TEE probe surface modification by preventing adhesion of macromoleculars ( Saliva).